It regulates tumor growth and apoptotic resistance via AKT signaling in colorectal cancer (34), and co-overexpression with APE1 correlates with aggressive phenotypes and poor prognosis in bladder cancer (35). The gene discussed is APEX1; the disease is urinary bladder cancer.